BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1865964)

  • 1. [Drug treatment of compulsive disorder].
    Rapoport JL
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of drugs in the treatment of obsessive-compulsive disorders].
    den Boer JA; Westenberg HG
    Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP; Miller JA; Sheehan DV; Fanous BS
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic antidepressants and obsessive-compulsive disorder.
    Cialdella P; Boissel JP
    Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive disorder and its treatment with serotonin-selective agents.
    Murphy DL; Pigott TA
    Prog Clin Biol Res; 1990; 361():179-201. PubMed ID: 2290841
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptom relapse in bulimia nervosa and obsessive compulsive disorder after treatment with serotonin antagonists.
    Hollander E; Mullen LS; Carrasco JL; DeCaria CM; Stein DJ
    J Clin Psychiatry; 1992 Jan; 53(1):28. PubMed ID: 1737737
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
    Greist JH
    J Clin Psychiatry; 1990 Aug; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compulsive personality as predictor of response to serotoninergic antidepressants.
    Ansseau M; Troisfontaines B; Papart P; von Frenckell R
    BMJ; 1991 Sep; 303(6805):760-1. PubMed ID: 1932937
    [No Abstract]   [Full Text] [Related]  

  • 10. New findings in obsessive-compulsive disorder.
    Kim SW; Dysken MW
    Minn Med; 1989 Feb; 72(2):91-3, 110. PubMed ID: 2651867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 12. Obsessive-compulsive disorder.
    Zetin M; Kramer MA
    Hosp Community Psychiatry; 1992 Jul; 43(7):689-99. PubMed ID: 1516899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of obsessive-compulsive disorder.
    Veale D
    Br J Hosp Med; 1990 Apr; 43(4):278-81. PubMed ID: 2189520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidepressive agents in the treatment of obsessive-compulsive disorder].
    Hansen ES; Bolwig TG
    Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092
    [No Abstract]   [Full Text] [Related]  

  • 15. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
    Murphy DL; Pato MT; Pigott TA
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM; Alcántara AG; Barcia D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.